6Barbier GH,Shettigar UR,Appunn DO.Clinical rationale for the use of an ultra-short acting beta-blocker:esmolol[J].Int J Clin Pharmacol Ther,1995,33(4):212-218.
7Theochari E,Xanthos T,Papadimitriou D,et al.Selective beta block-ade improves the outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest[J].Ann Ital Chir,2008,79(6):409-414.
8Halvorsen PS,Remme EW,Espinoza A,et al.Automatic real-time detection of myocardial ischemia by epicardial accelerometer[J].J Thorac Cardiovasc Surg,2010,139(4):1026-1032.
9Bessho R,Chambers DJ.Myocardial protection:The efficacy of an ultra-shortactingβ-blocker,esmolol,as a cardioplegic agent.Cardio-pulmonary Support and Physiology[J].J Thorac Cardiovasc Surg,2001,122(5):993-1003.
10Suttner S,Boldt J,Lang K,et al.Continuous beta-block with es-moloo in combination with enoximone:influence on cardiac func-tion in high risk patients undergoing vascular surgery[J].Anaesthe-sist,2008,57(3):231-234.
